MCEF is localized to the nucleus by protein sequences encoded within three distinct exons, where it represses HIV-1 Tat-transactivation of LTR-directed transcription

International Journal of Biological Sciences

Volumn 3, Issue 4, 2007, Pages 225-236

  Niedzielski, Maksymilian F ^a,b   Hopewell, Robert ^a   Ismail, Zohra ^a   Estable, Mario C ^a,b  

^a RYERSON UNIVERSITY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Af5q31; AFF4; HIV; MCEF; NLS; Tat; Transcription

Indexed keywords

AF4 PROTEIN; PROTEIN MCEF; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EXON; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN FUNCTION; PROTEIN STRUCTURE;

BILATERIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33947275657     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3.225     Document Type: Article

References (33)

1. Orlando V. Polycomb, epigenomes, and control of cell identity. Cell 2003; (112): 599-606
2. Yu BD, Hanson RD, Hess JL, Horning SE, and Korsmeyer SJ. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proc Natl Acad Sci U S A 1998; (95): 10632-10636
3. Ayton PM, and Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001; (20): 5695-5707
4. Bursen A, Moritz S, Gaussmann A, Moritz S, Dingermann T, and Marschalek R. Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology? Oncogene 2004; (23): 6237-6249
5. Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, and Look AT. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 2003; (102): 262-268
6. Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Silverman GA, Kersey JH, and Korsmeyer SJ. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci U S A 1993; (90): 7884-7888
7. Hiwatari M, Taki T, Taketani T, Taniwaki M, Sugita K, Okuya M, Eguchi M, Ida K, and Hayashi Y. Fusion of an AF4-related gene, LAF4, to MLL in childhood acute lymphoblastic leukemia with t(2;11)(q11;q23). Oncogene 2003; (22): 2851-2855
8. von Bergh AR, Beverloo HB, Rombout P, van Wering ER, van Weel MH, Beverstock GC, Kluin PM, Slater RM, and Schuuring E. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Genes Chromosomes Cancer 2002; (35): 92-96
9. Taki T, Kano H, Taniwaki M, Sako M, Yanagisawa M, and Hayashi Y. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc Natl Acad Sci U S A 1999; (96): 14535-14540
10. Estable MC, Naghavi MH, Kato H, Xiao H, Qin J, Vahlne A, and Roeder RG. MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein. J Biomed Sci 2002; (9): 234-245
11. Imamura T, Morimoto A, Ikushima S, Kakazu N, Hada S, Tabata Y, Yagi T, Inaba T, Hibi S, Sugimoto T, and Imashuku S. A novel infant acute lymphoblastic leukemia cell line with MLL-AF5q31 fusion transcript. Leukemia 2002; (16): 2302-2308
12. Deveney R, Chervinsky DS, Jani-Sait SN, Grossi M, and Aplan PD. Insertion of MLL sequences into chromosome band 5q31 results in an MLL-AF5Q31 fusion and is a rare but recurrent abnormality associated with infant leukemia. Genes Chromosomes Cancer 2003; (37): 326-331
13. Wain HM, Lush MJ, Ducluzeau F, Khodiyar VK, and Povey S. Genew: the Human Gene Nomenclature Database. 2004 updates. Nucleic Acids Res 2004; (32): D255-257
14. Prasad R, Yano T, Sorio C, Nakamura T, Rallapalli R, Gu Y, Leshkowitz D, Croce CM, and Canaani E. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc Natl Acad Sci U S A 1995; (92): 12160-12164
15. Baskaran K, Erfurth F, Taborn G, Copeland NG, Gilbert DJ, Jenkins NA, Iannaccone PM, and Domer PH. Cloning and developmental expression of the murine homolog of the acute leukemia proto-oncogene AF4. Oncogene 1997; (15): 1967-1978
16. Bitoun E, and Davies KE. The robotic mouse: unravelling the function of AF4 in the cerebellum. Cerebellum 2005; (4): 250-260
17. Hillman MA, and Gecz J. Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. J Hum Genet 2001; (46): 251-259
18. To MD, Faseruk SA, Gokgoz N, Pinnaduwage D, Done SJ, and Andrulis IL. LAF-4 is aberrantly expressed in human breast cancer. Int J Cancer 2005; (115): 568-574
19. Britanova O, Lukyanov S, Gruss P, and Tarabykin V. The mouse Laf4 gene: exon/intron organization, cDNA sequence, alternative splicing, and expression during central nervous system development. Genomics 2002; (80): 31-37
20. Urano A, Endoh M, Wada T, Morikawa Y, Itoh M, Kataoka Y, Taki T, Akazawa H, Nakajima H, Komuro I, Yoshida N, Hayashi Y, Handa H, Kitamura T, and Nosaka T. Infertility with defective spermiogenesis in mice lacking AF5q31, the target of chromosomal translocation in human infant leukemia. Mol Cell Biol 2005; (25): 6834-6845
21. Wittwer F, van der Straten A, Keleman K, Dickson BJ, and Hafen E. Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. Development 2001; (128): 791-800
22. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; (431): 931-945
23. Horowitz DS, and Krainer AR. Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet 1994; (10): 100-106
24. Nilson I, Reichel M, Ennas MG, Greim R, Knorr C, Siegler G, Greil J, Fey GH, and Marschalek R. Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia. Br J Haematol 1997; (98): 157-169
25. Rechsteiner M, and Rogers SW. PEST sequences and regulation by proteolysis. Trends Biochem Sci 1996; (21): 267-271
26. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, and Sadowski IJ. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996; (70): 4053-4062
27. Estable MC, Bell B, Hirst M, and Sadowski I. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J Virol 1998; (72): 6465-6474
28. Peterson KJ, Lyons JB, Nowak KS, Takacs CM, Wargo MJ, and McPeek MA. Estimating metazoan divergence times with a molecular clock. Proc Natl Acad Sci U S A 2004; (101): 6536-6541
29. Poon IK, and Jans DA. Regulation of nuclear transport: central role in development and transformation? Traffic 2005; (6): 173-186
30. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 1999; (234): 187-208
31. Reynolds L, Ullman C, Moore M, Isalan M, West MJ, Clapham P, Klug A, and Choo Y. Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc Natl Acad Sci U S A 2003; (100): 1615-1620
32. Chen J, Malcolm T, Estable MC, Roeder RG, and Sadowski I. TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF. J Virol 2005; (79): 4396-4406
33. Estable MC, Hirst M, Bell B, O'Shaughnessy MV, and Sadowski I. Purification of RBF-2, a transcription factor with specificity for the most conserved cis-element of naturally occurring HIV-1 LTRs. J Biomed Sci 1999; (6): 320-332